Skip to content
sellWeak cluster of 2

Nicholas Hollmeyer Lynton sold $9,454 of CDLX

Chief Legal & Privacy Officer at Cardlytics, Inc.. 2,151 shares at an average of $4.40, traded Jul 2, 2026, filed Jul 6, 2026.

Warning score
13
Value
$9,454
2,151 shares
Holdings after
19,353
-10% from before
From 52-week low
+1%
low $4.44, close $4.47
From 52-week high
-86%
high $31.20, as of Jul 2, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $9k at market
    0
  • Share of holdings sold
    Sold 10% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CDLXOct 12, 2026 · close 2.24
Since filing Jul 6, 2026: -48.7%SPY +3.8% · excess -52.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-26-047389, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2026MOption exercise
Common Stock
+157--16,942Jul 6, 2026
Jul 1, 2026MOption exercise
Common Stock
+1,500--18,442Jul 6, 2026
Jul 1, 2026MOption exercise
Common Stock
+312--18,754Jul 6, 2026
Jul 1, 2026MOption exercise
Common Stock
+2,750--21,504Jul 6, 2026
Jul 2, 2026SOpen-market sale
Common Stock
-2,151$4.40$9,45419,353Jul 6, 2026
Jul 1, 2026MOption exercise
Restricted Stock Unitsderivative
-157$0.00$00Jul 6, 2026
Jul 1, 2026MOption exercise
Restricted Stock Unitsderivative
-1,500$0.00$04,500Jul 6, 2026
Jul 1, 2026MOption exercise
Restricted Stock Unitsderivative
-312$0.00$0938Jul 6, 2026
Jul 1, 2026MOption exercise
Restricted Stock Unitderivative
-2,750$0.00$019,250Jul 6, 2026

Related signals

Other insiders at Cardlytics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$47k
17,733 shares
-11%
17Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$54k
13,461 shares
-10%
31Weak
CDLXsell 2
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$71k
16,138 shares
-12%
61Notable
CDLXbuy
Cardlytics, Inc.
David Thomas Evans
Chief Financial Officer
$129k
200,000 shares
+170%
42Moderate
CDLXsell 2
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$83k
69,833 shares
-7%
19Weak
CDLXsell 2
Cardlytics, Inc.
Nicholas Hollmeyer Lynton
Chief Legal & Privacy Officer
$40k
40,296 shares
-19%
28Weak
CDLXsell 2
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$118k
116,774 shares
-10%
24Weak
CDLXsell
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$89k
97,208 shares
-13%
22Weak
CDLXsell 3
Cardlytics, Inc.
Alexis DeSieno
Chief Financial Officer
$10k
8,607 shares
-4%
25Weak
CDLXsell 3
Cardlytics, Inc.
Amit Gupta
Chief Executive Officer
$6,794
5,807 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nicholas Hollmeyer Lynton sold $9,454 of CDLX | InsiderTell